Preventing Corneal Transplant Rejection | Action Medical Research | Children's Charity

Corneal transplantation ­preventing transplant rejection

This research was completed on 30 September 2004

Project LeaderDr Andrew J T George MA PhD MRCPath and Mr Daniel F P Larkin MD
LocationDepartment of Immunology, Hammersmith Hospital in conjunction with Moorfields Eye Hospital, London.
Grant awarded26 October 2000
Start date1 October 2001
End date30 September 2004
Grant amount£124,279.00
Grant codeSP3683

We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.

Corneal grafting is the most common form of transplantation and a major way of treating and reversing blindness, with 60-80,000 operations performed worldwide each year. About a quarter of all these grafts fail within 5 years, and in some groups of patients (such as children or those with eye infections) the majority are rapidly rejected. This team is working to prevent such corneal rejection by using molecules which are normally used by viruses to protect themselves from the immune system. (The molecules confuse the immune system and prevent it from attacking the virus.) The aim of this study is to cause the corneas to make these particular molecules, in order to similarly confuse the immune system and thereby stop it from attacking the graft.

Help us spread the word